
Naini industrial area entrepreneurs to benefit from new door to door garbage collection service
Prayagraj: The entrepreneurs of Naini Industrial Area will no longer have to worry about garbage disposal. Uttar Pradesh State Industrial Development Authority (UPSIDA) will now collect garbage from the factories of Naini Industrial Area through door-to-door garbage collection.
UPSIDA will not charge entrepreneurs a higher fee but will only charge a maintenance fee of Rs 1 per square metre per year. Until now, the entrepreneurs themselves disposed of the waste from the factories.
To solve the problems of entrepreneurs and provide them with maximum facilities, a Samadhan Diwas and Samvad programme was organised with the entrepreneurs of Prayagraj division in Naini Industrial Area on May 2 under the chairmanship of Uttar Pradesh govt's industrial development minister, Nand Gopal Gupta Nandi.
The entrepreneurs demanded improvements in electricity, water, cleanliness and other basic facilities in Prayagraj industrial area.
Minister Nandi assured the entrepreneurs of these improvements.
UPSIDA previously charged Rs 20 per square metre per year from the entrepreneurs of Naini industrial area as a maintenance fee, which did not include garbage disposal. The entrepreneurs had to remove garbage from their enterprises themselves, incurring additional costs.
To address this issue, UPSIDA has now decided to dispose of the garbage by conducting door-to-door garbage collection from the factories established in Naini industrial area.
The pre-determined maintenance fee of Rs 20 has been increased by just one rupee, making the maintenance fee Rs 21. Now, the entrepreneurs have resolved the problem of garbage disposal at a fee of just one rupee per square metre per year.
President of Eastern Chamber of Commerce, Vinay Kumar Tandon, said that the entrepreneurs will benefit from this facility provided by UPSIDA.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
16 hours ago
- Time of India
UP inks Rs 435cr MoUs at Ahmd roadshow
Lucknow: Inviting pharma sector players to come and invest in UP during a roadshow in Ahmedabad on Friday, CEO of UP state industrial development authority (UPSIDA), Mayur Maheshwari said that a new era for the pharma sector is taking place in UP. "UP is developing a bulk drug pharma park on 1,472.33 acre in Lalitpur, with a proposed investment of approximately Rs250 crore. This project is a significant step towards making the country self-reliant in the pharmaceutical sector and establishing India as the 'Pharmacy of the world'," he said, adding, "it will not only attract substantial investment but also create new employment opportunities for the skilled workforce in the state. " Several agreements were signed by UPSIDA with pharma companies on the occasion. The list includes CSL Lifesciences Private Limited, which proposed an investment of Rs 200 crore for establishing an intravenous bottle plant and oral solid dosage plant within the next two years. Likewise, Medihealth Diagnostic Pvt Ltd will establish a healthcare unit on 4,200 sqmt in Lalitpur, while Gaman Irradiation Company will invest Rs 35 crore in a skin treatment and irradiation unit. Creating employment for 150 people, the project will be implemented in 24-36 months. Additionally, Obmed Pharma has decided to invest Rs 200 crore to establish a formulation unit. Spread across five acre of land in Lalitpur, the unit will create employment for around 100 people. Several business-to-govt meetings were held, where detailed discussions on investment-related topics took place between industry representatives and govt officials. Earlier, in the welcome address, convenor of CII Gujarat pharma and healthcare panel, Swapnil Shah highlighted investment opportunities in UP. Advisor to UP CM, GN Singh said, "UP emerged as the most suitable state for investment in the pharma sector". He shared detailed information about the efforts made by the state govt to empower the pharma sector. An 'Open House' session followed, where participants engaged in direct dialogue with state govt officials to resolve their queries and concerns. The programme concluded with a vote of thanks by chairman of Shalby Ltd, Shanay Shah. Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !


Indian Express
a day ago
- Indian Express
Road show on investment opportunities in UP held in Ahmedabad: UPSIDA
The Uttar Pradesh State Industrial Development Authority (UPSIDA) organised a roadshow on Friday in Ahmedabad on the theme 'Investment Opportunities in Uttar Pradesh's Pharmaceutical Sector.' The primary objective of this event was to apprise investors of the vast opportunities available in Uttar Pradesh's growing pharmaceutical industry and to invite them to explore business prospects within the state, a statement said. The event saw participation from key stakeholders in the pharma sector, including industry leaders, investors and policymakers. UPSIDA is developing a Bulk Drug Pharma Park spread across 1,472.33 acres in the Lalitpur district, with a proposed investment of approximately Rs 250 crore. This Pharma Park is estimated to attract an investment of approximately Rs 12000 crore. The event commenced with the registration process, followed by a welcome address by Swapnil Shah, Convenor of the CII Gujarat Pharma & Healthcare Panel and CEO & MD of Senores Pharmaceuticals Ltd. A short film showcasing Uttar Pradesh's industrial growth, investor-friendly policies, and robust infrastructure was presented to give investors a comprehensive overview of the state's potential, said the statement. In his address, UPSIDA CEO Mayur Maheshwari emphasised the rapid development of pharma parks in Uttar Pradesh. He elaborated on the investment process, land allotment, and the range of facilities available to industries, extending a direct invitation to Gujarat-based entrepreneurs to invest in the state. During the investment session held in Ahmedabad, UPSIDA signed several Memorandums of Understanding (MoUs) with leading pharmaceutical and healthcare companies.


Time of India
2 days ago
- Time of India
UP to hold roadshow in Ahmedabad to boost pharma sector investment
Lucknow: The Yogi government, in collaboration with the UP State Industries Development Authority and Confederation of Indian Industry, is set to host a roadshow in Ahmedabad on Friday to showcase opportunities in the pharmaceutical sector. An official spokesperson stated that the pharma sector is a key catalyst towards achieving the one trillion-dollar economy goal. Senior officials, including Mayur Maheshwari, CEO of UPSIDA, and Awanish Kumar Awasthi, advisor to the CM, are likely to address the business community in the Gujarat capital. The state govt is actively promoting the sector through initiatives like the creation of mega drug parks and the establishment of dedicated institutions for pharma research and innovation. These efforts are built on the existing base, which includes the presence of the Central Drug Research Institute lab and a large number of pharmaceutical units, particularly in the formulation sector, located in districts like Ghaziabad, Lucknow, and Kanpur. Additionally, the state has a robust network of pharma educational institutes. "The govt is actively fostering innovation and entrepreneurship in the pharmaceutical sector through the establishment of incubation centres and 'Promote Pharma', a dedicated institution for pharma research and innovation," said a govt officer. An assessment by Invest UP shows that the pharmaceutical sector attracted nearly Rs 2,845 crore in investment and generated over 70,000 jobs in three years. "Over the past three years, the state attracted investments worth approximately Rs 2,845 crore in the pharmaceutical sector via the single window portal. This includes investments in manufacturing units, blood centres, and drug retail establishments," the officer stated. Between 2022–23 and 2024–25, around 167 manufacturing units were set up, creating about 3,340 jobs. In the same period, 195 blood centres and 32,475 medicine retail outlets were also established, creating approximately 1,365 and 64,995 jobs, respectively. The Pharmaceutical and Medical Device Policy, 2023 has further strengthened investor confidence. The policy offers several incentives, including a stamp duty exemption of Rs 3.89 crore, encouraging new investments and the expansion of existing businesses. This has led to a spike in both manufacturing facilities and retail operations within the state. The list of investment opportunities also includes the development of the Lalitpur Bulk Drug Park, which is progressing significantly.